Primary gastric lymphoma (PGL) is the most common extranodal non-Hodgkin lymphoma
and represents a wide spectrum of disease, ranging from indolent low-grade marginal zone …

Non-Hodgkin lymphomas represents a heterogeneous group of lymphoproliferative
disorders characterized by different clinical courses, varying from indolent to highly …

Abstract FDG‐PET/CT is the current state‐of‐the‐art imaging in lymphoma and plays a
central role in treatment decisions. At diagnosis, accurate staging is crucial for appropriate …

Since the mid-1990s, 18F-fluorodeoxglucose (FDG)-positron emission tomography (PET) in
combination with computed tomography has come to play a prominent role in the …

Abstract UNFOLDER (Unfavorable Young Low-Risk Densification of R-Chemo Regimens) is
an international phase-3 trial in patients 18–60 years with aggressive B-cell lymphoma and …

Malignant lymphoma comprises a broad spectrum of diverse entities originating from
different types of lymphocytes. In the last century, successive improvements of treatment …

The role of radiotherapy in the treatment of lymphoma is rapidly evolving. The development
of modern systemic therapies and the adoption of FDG-PET-scanning as metabolic …

FDG-PET scanning has a central role in lymphoma staging and response assessment.
There is a growing body of evidence that PET response assessment during and after initial …

Radiotherapy (RT) plays a diverse and essential role in the contemporary management of
non-Hodgkin lymphoma (NHL) and remains the single most powerful monotherapeutic …

Over the course of many decades, combined chemotherapy and radiotherapy adapted to the
stage of disease have become the optimal and standard treatment for Hodgkin lymphoma …